Friday - April 26, 2024

Category Archives: Finance

Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Eli Lilly, Genentech, BioNTech, Xencor, Celgene

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 40+ key pharma and biotech companies are working on 40+ pipeline drugs in the Extensive-Stage Small Cell Lung Cancer (ESCLC) therapeutics landscape based on different Routes of Administration (ROA), Mechanism … Continue reading →

Systemic Sclerosis Market to Exhibit Substantial Growth Rate During the Forecast Period (2023-2032) – DelveInsight | Eicos Sciences, Cytori, Corbus Pharmaceuticals, Emerald Health, Kyowa Kirin

Delveinsight Business Research LLP As per DelveInsight, the Systemic Sclerosis Market is anticipated to evolve immensely in the coming years owing to the rising prevalent population of Systemic Sclerosis (SSc) patients in the 7MM and the launch of novel therapies … Continue reading →

Congenital Hyperinsulinism Market to Register Stunning Growth During the Forecast Period (2023-2032) – DelveInsight | Key Companies – Zealand Pharma, Rezolute, Hanmi Pharmaceutical, Crinetics

Delveinsight Business Research LLP In 2021, the Congenital Hyperinsulinism Market size was USD 103 million in the 7MM, which is expected to grow by 2032. As per DelveInsight, the Congenital Hyperinsulinism Market is anticipated to evolve immensely in the coming … Continue reading →

Generalized Myasthenia Gravis (gMG) Market to Register Immense Growth During the Forecast Period (2023-2032) – DelveInsight | Key Companies – AbbVie, Alexion, Amgen, Argenx, Biocon, Biogen, BioMarin

DelveInsight Business Research LLP The Generalized Myasthenia Gravis (gMG) market size in the 7MM was USD 2,690 million in 2021, which is expected to grow by 2032. The gMG Market is anticipated to evolve immensely in the coming years owing … Continue reading →